- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Stock Issued | Q1 2026 · Mar 31, 2026 | 1.26K sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 101.45M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 102.8M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $6.08M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $26.37M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $162.61M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $159.07M |
| Capex | Q1 2026 · Mar 31, 2026 | $33.14M |
| Capex | Q1 2026 · Mar 31, 2025 | $29.89M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $147.39M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $127.75M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $3.25B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $3.17B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $242.21M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $250.04M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $39.27M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $64.81M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $734.97M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $794.04M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.93B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.91B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $426.39M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $459.72M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.91B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.93B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.35 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.35 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $97.58M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $94.99M |
| Net Income | Q1 2026 · Mar 31, 2026 | $101.29M |
| Net Income | Q1 2026 · Mar 31, 2025 | $138.76M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $146.06M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $191.23M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $183.32M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $180M |